6. Atopic disease in childhood

Medical Journal of Australia

Volumn 182, Issue 6, 2005, Pages 298-304

  Gold, Michael S ^a   Kemp, Andrew S ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CALCINEURIN INHIBITOR; CASEIN; CYCLOSPORIN; FISH OIL; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; MONTELUKAST; OMEGA 3 FATTY ACID; OVALBUMIN; PIMECROLIMUS; POLLEN EXTRACT; PROBIOTIC AGENT; PROMETHAZINE; STEROID; TACROLIMUS; TOPICAL AGENT;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIBODY PRODUCTION; ARTICLE; ASTHMA; ATOPY; BREAST FEEDING; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; DANDER; DERMATOPHAGOIDES; DESENSITIZATION; DISEASE COURSE; ECZEMA; ENVIRONMENTAL FACTOR; FOOD ALLERGY; HAY FEVER; HEREDITY; HIGH RISK PATIENT; HUMAN; IMMUNOTHERAPY; MILK ALLERGY; MOULD; PALLIATIVE THERAPY; POLLEN; POLLEN ALLERGY; PREVALENCE; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; RHINITIS; RHINOCONJUNCTIVITIS; SKIN TEST; ALLERGIC CONJUNCTIVITIS; CASE REPORT; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GENETICS; HYPERSENSITIVITY; INFANT; MALE; METHODOLOGY; REVIEW; RISK FACTOR;

ALLERGENS; ASTHMA; CHILD; CONJUNCTIVITIS, ALLERGIC; ECZEMA; ENVIRONMENTAL EXPOSURE; FOOD HYPERSENSITIVITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INFANT; MALE; RHINITIS; RISK FACTORS; SKIN TESTS;

EID: 15844372639     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06707.x     Document Type: Article

References (35)

1. Nickel R, Lau S, Niggemann B, et al. Messages from the German Multicentre Allergy Study. Pediatr Allergy Immunol 2002; 13 Suppl 15: 7-10.
2. Halapi E, Hakonarson H. Recent development in genomic and proteomic research for asthma. Curr Opin Pulm Med 2004; 10: 22-30.
3. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-1232.
4. Check E. Link from hygiene to allergies gains support. Nature 2004; 428: 354.
5. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869-877.
6. Ponsonby AL, Couper D, Dwyer T, et al. Relationship between early life respiratory illness, family size over time, and the development of asthma and hay fever: a seven year follow up study. Thorax 1999; 54: 664-669.
7. Almqvist C, Egmar AC, Hedlin G, et al. Direct and indirect exposure to pets - risk of sensitization and asthma at 4 years in a birth cohort. Clin Exp Allergy 2003; 33: 1190-1197.
8. Robertson CF, Roberts MF, Kappers JH. Asthma prevalence in Melbourne schoolchildren: have we reached the peak? Med J Aust 2004; 180: 273-276.
9. Sampson HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol 1999; 103: 981-989.
10. Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984; 74: 26-33.
11. Hill DJ, Hosking CS, Reyes-Benito LV. Reducing the need for food allergen challenges in young children: a comparison of in vitro with in vivo tests. Clin Exp Allergy 2001; 31: 1031-1035.
12. Sampson HA. Use of food-challenge tests in children. Lancet 2001; 358: 1832-1833.
13. Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101(3): E8.
14. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy and/or lactation for preventing or treating atopic disease in the child (Cochrane review). The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
15. Cavagni G, Paganelli R, Caffarelli C, et al. Passage of food antigens into circulation of breast-fed infants with atopic dermatitis. Ann Allergy 1988; 61: 361-365.
16. Vanlaar CH, Peat JK, Marks GB, et al. Domestic control of house dust mite allergen in children's beds. J Allergy Clin Immunol 2000; 105(6 Pt 1): 1130-1133.
17. Gøtzsche PC, Johansen HK, Burr ML, Hammarquist C. House dust mite control measures for asthma (Cochrane review). The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
18. Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis (Cochrane review). The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
19. Holm L, Bengtsson A, van Hage-Hamsten M, et al. Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration. Allergy 2001; 56: 152-158.
20. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993; 129: 422-430.
21. Murphy LA, Atherton D. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol 2002; 147: 308-315.
22. Katelaris CH, Weiner JM, Heddle RJ, et al, for the Australian College of Allergy. Vega testing in the diagnosis of allergic conditions [position statement]. Med J Aust 1991; 155: 113-114.
23. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 2000; 22: 329-341.
24. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther 2000; 22: 342-350.
25. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; (2): CD002893.
26. Specific allergen immunotherapy for asthma. A position paper of the Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy. Med J Aust 1997; 167: 540-544.
27. Boros CA, Kay D, Gold MS. Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paediatr Child Health 2000; 36: 36-40.
28. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003; 3: 313-318.
29. van Odijk J, Kull I, Borres MP, et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy 2003; 58: 833-843.
30. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
31. Hodge L, Salome CM, Peat JK, et al. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164: 137-140.
32. Dunstan JA, Dipa PG, Mori TA, et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 2003; 112: 1178-1184.
33. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants (Cochrane review). The Cochrane Library; Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
34. Osborn DA, Sinn J. Soy formula for prevention of allergy and food intolerance in infants (Cochrane review). The Cochrane Library Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
35. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Handbook series on preparing clinical practice guidelines. Table 1.3: Designation of levels of evidence. Canberra: NHMRC, February 2000: 8. Available at: www.health.gov.au/nhmrc/publications/pdf/cp69.pdf (accessed Feb 2005).